Haleon Future Growth
Future criteria checks 1/6
Haleon is forecast to grow earnings and revenue by 12% and 4.3% per annum respectively. EPS is expected to grow by 12.2% per annum. Return on equity is forecast to be 10% in 3 years.
Key information
12.0%
Earnings growth rate
12.2%
EPS growth rate
Personal Products earnings growth | 20.3% |
Revenue growth rate | 4.3% |
Future return on equity | 10.0% |
Analyst coverage | Good |
Last updated | 28 Jun 2024 |
Recent future growth updates
Recent updates
The Investment Case For Haleon: Steady Shareholder Value Accumulation
Nov 20The Share Price Has The Flu, But Haleon Is As Healthy As An Ox
Sep 07Haleon: A Hidden Gem In The Consumer Health Market
Jun 12Haleon exploring sale of ChapStick Brand - report
Feb 25Haleon said to evaluate potential deals to increase its size - report
Jan 31Haleon: Undervalued With Clear Catalyst Ahead
Aug 31Former GSK consumer health unit Haleon hits all-time low
Aug 19Haleon CEO says brand recognition, gross margins will drive growth - CNBC
Jul 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 12,493 | 1,854 | 1,963 | N/A | 14 |
12/31/2025 | 11,943 | 1,711 | 1,778 | N/A | 16 |
12/31/2024 | 11,451 | 1,490 | 1,552 | N/A | 16 |
3/31/2024 | 11,235 | 1,083 | N/A | N/A | N/A |
12/31/2023 | 11,302 | 1,049 | 2,010 | 2,100 | N/A |
9/30/2023 | 11,314 | 1,250 | N/A | N/A | N/A |
6/30/2023 | 11,408 | 1,230 | 1,796 | 2,132 | N/A |
3/31/2023 | 11,217 | 1,106 | N/A | N/A | N/A |
12/31/2022 | 10,858 | 1,060 | 1,771 | 2,063 | N/A |
9/30/2022 | 10,560 | 1,390 | N/A | N/A | N/A |
6/30/2022 | 10,158 | 1,416 | 1,604 | 1,802 | N/A |
3/31/2022 | 9,866 | 1,500 | N/A | N/A | N/A |
12/31/2021 | 9,545 | 1,390 | 1,195 | 1,356 | N/A |
12/31/2020 | 9,892 | 1,145 | 2,013 | 1,407 | N/A |
12/31/2019 | 8,480 | 655 | 663 | 786 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HLN's forecast earnings growth (12% per year) is above the savings rate (2.4%).
Earnings vs Market: HLN's earnings (12% per year) are forecast to grow slower than the US market (14.7% per year).
High Growth Earnings: HLN's earnings are forecast to grow, but not significantly.
Revenue vs Market: HLN's revenue (4.3% per year) is forecast to grow slower than the US market (8.6% per year).
High Growth Revenue: HLN's revenue (4.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HLN's Return on Equity is forecast to be low in 3 years time (10%).